Next-Generation Biotech & Healthcare: Implications for Scientists, Physicians, Investors, and Patients

The biotech and healthcare sectors are experiencing swift and profound changes, fueled by cutting-edge innovations that are poised to redefine how we diagnose, treat, and care for patients. Breakthroughs in artificial intelligence, precision medicine, gene editing, and sophisticated biomanufacturing are coming together to create healthcare solutions that are more targeted, individualized, and widely available. These advancements are broadening the range of available treatments while also enhancing the precision, pace, and scalability of medical care, heralding a transformative phase in medicine. Collectively, these innovations are reshaping the healthcare landscape, opening new possibilities for patients facing once-untreatable conditions and ushering in a future where care is both more efficient and patient-focused.

MODERATOR:

Jeffrey Hausfeld, M.D., M.B.A., F.A.C.S.
Chairman of the Board and Chief Medical Officer at BioFactura, Inc. & Chairman and Founder of the Society of Physician Entrepreneurs
Jeffrey Hausfeld, M.D., M.B.A., F.A.C.S., has served on the national board and committees of specialty medical societies since he began his practice in Otolaryngology/Facial Plastic Surgery in 1982. He is an Associate Clinical Professor of Surgery at George Washington University School of Health Sciences and an alumnus of the Yale University School of Medicine. Dr. Hausfeld is widely published in the medical literature, is the pioneer of innovative laser surgery techniques, is the author of a lay oriented medical book on snoring and sleep apnea, and has appeared on numerous local and national television and radio shows as a medical expert. Read full profile…

PANEL:

Murat Kalayoglu
Co-Founder & Managing Partner, SOAR Bio
Dr. Kalayoglu is co-founder and managing partner at SOAR Bio, a therapeutics-focused venture studio in Greater Washington. Prior to SOAR Bio, he was co-founder and CEO of Cartesian Therapeutics (NASDAQ: RNAC), which he led from concept to proof-of-concept clinical trials, followed by a public listing in 2023. Prior to Cartesian, Dr. Kalayoglu was co-founder and CEO of Topokine, which he led from concept to late-stage clinical trials, followed by a successful sale to Abbvie (NYSE:ABBV) in 2016. Read full profile…

Christopher Montalbano
CEO & Engineering Development Leader, MIDI
Chris is the Co-Founder and Engineering Leader of MIDI. Educated in mechanical engineering at Rensselaer Polytechnic Institute, he graduated with his Engineering Masters and later obtained a Master’s in Business Administration from Hofstra University. While teaching materials engineering, he joined MIDI in 1988 with the pursuit of product excellence, forward thinking and innovation for MIDI’s clients in the medical, life science and home healthcare markets. Read full profile…

Deanne Randolph
Founder and CEO, Lumigen Biotechnology
Deanne Randolph is the Founder and CEO of Lumigen Biotechnology, pioneering antibody-nanoparticle conjugates to precisely treat glioblastoma and brain metastases – areas of dire unmet medical need where traditional therapies struggle to reach their targets. She brings more than 20 years of experience building and leading organizations that translate innovation into patient impact. Read full profile…

Caitlin Wheatley
Senior Operations Manager, Johnson & Johnson Innovation
Caitlin Wheatley has extensive experience and leadership within the Biotech Industry and Innovation space. Currently, she holds the position of Senior Operations Manager at JLABS Washington, D.C. (Johnson & Johnson’s startup incubator). Previous roles include Director of Quality Control at Alphazyme, Bioanalytical Lab Manager at Meso-Scale Diagnostics, Lab Manager at Cantel Medical, and Lean Program Manager at Eurofins Scientific. Read full profile…